Total: $199.4M

Company
(Symbol)#

Type Of
Financing

Number
Of Shares, Units Or Warrants (M)

Amount Raised (M)

Investors; Placement Agents;
Details (Date)@


Advanced Viral
Research Corp.
(OTC BB:ADVR)

Private placement of convertible debentures

N/A

$1.5

Advanced Viral Research raised $1.5M with the sale of $1M in its convertible debentures to board member James Dicke and $500,000 worth to board member Peter Lunder (7/16)

Biosyntech Inc.
(Canada; OTC BB:BSYI)

Equity line of
credit

N/A

Biosyntech received a C$1.2M (US$789,000) line of credit from the National Bank of Canada (7/8)

Bioxel Pharma
Inc.
(Canada; CDNX:BIP)

Private placement of convertible debentures

N/A

C$2.5 (US$1.6)

Bioxel Pharma closed its private placement of US$1.6M (7/16)

Boston Life
Sciences Inc.
(BLSI)

Private placement of a convertible senior secured promissory note

N/A

$4

Boston Life Sciences raised $4M in the sale of a 10% convertible senior secured promissory note to a single institutional investor (7/26)

Cel-Sci Corp.
(AMEX:CVM)

Private placement of common stock

N/A

$1.3

Company raised $1.3M in a placement with two unnamed investors (7/17)

Cohesion
Technologies

Inc.
(CSON)

Private placement of common stock and warrants

8.2S and
W for 0.9S

$13.2

Cohesion Technologies expected to raise $13.2M in the private placement with Three Arch Partners and Alta Partners; net proceeds were expected to be about $12.4M (7/26)

Cytomedix Inc.
(OTC BB:
CYDX)

Private placement of common stock

N/A

$3.1

Cytomedix raised $3.1M in a private placement (7/11)

Deltagen Inc.
(DGEN)

Equity lines of credit

N/A

$10

Deltagen signed two financing agreements, one for a $20M term loan and another for a one-year $5M accounts receivable loan; Deltagen drew down $10M from the term loan (7/1)

Genelabs
Technologies

Inc.
(GNLB)

Private placement of common stock

3.1S

$6.4

Genelabs raised about $6.4M with the sale of 3.1M shares to institutional investors (7/10)

NeoTherapeutics
Inc.
(NEOT)

Private placement of common stock

6.47S

$1.1

NeoTherapeutics raised $1.1M through the sale of 6,470,588 shares of stock to four institutional investors at 17 cents per share (7/12)

NexMed Inc.
(NEXM)

Private placement of common stock

2.7S

$6

NexMed raised more than $6M in gross proceeds from a private placement; investors were Capital Research and Management Co. and a mutual fund managed by an unnamed investment firm; Security Research Associates Inc. acted as placement agent (7/2)

Protalex Inc.
(OTC BB:PRTX)

Private placement of common stock and warrants

N/A

$1.2

Protalex raised $1.2M in the private placement (7/11)

Scios Inc.
(SCIO)

Private placement of convertible subordinated notes

N/A

$150

Scios raised $150M through the sale of 5.5% convertible subordinated notes due Aug. 15, 2009; purchasers also have an option on another $25M in principal amount to cover overallotments (7/31)


Notes:

This chart does not include real estate or manufacturing plant financings.

# Unless otherwise indicated, shares are traded on the Nasdaq exchange.

@ Dates refer to the date of the press release.

N/A = Not available, applicable or reported.

AMEX = American Stock Exchange; CDNX = Canadian Venture Exchange; OTC BB = Over the Counter Bulletin Board

No Comments